| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE | 2 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | Morphine Sulfate 1 mg/mL in 5% Dextrose 100 mL Bag | 2 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | Morphine Sulfate 2 mg/mL in 0.9% Sodium Chloride Syringe | 6 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | Morphine Sulfate 0.5 mg/mL in 0.9% Sodium Chloride 10 mL Syringe | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | Morphine Sulfate 5 mg/mL in 0.9% Sodium Chloride 30 mL Monoject Syringe Barrel | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE ER - C-II 15 mg TABLETS | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE ER - C-II TABLETS - 15MG, 30MG | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 7 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | These highlights do not include all the information needed to use Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Tablets. Morphine Sulfate Tablets, CII Initial U.S. Approval: 1984 | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | Morphine Sulfate Extended-Release Tablets CII 15 mg 30 mg 60 mg 100 mg* 200 mg* | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | AVINZA ® C II (morphine sulfate extended-release capsules) 30 mg, 45 mg, 60 mg, 75 mg, 90 mg, 120 mg R x Only | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | a6b1858a-e796-4cb0-8a4d-d5c521874e84 | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | These highlights do not include all the information needed to use Morphine Sulfate Oral Solution and Morphine Sulfate Tablets safely and effectively. See full prescribing information for Morphine Sulfate Oral Solution and Morphine Sulfate Tablets. Initial U.S. Approval: 1984 | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE ER 60 MG | 359 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED-RELEASE TABLETS 15 mg, 30 mg, 60 mg, 100 mg*, 200 mg* CII Rx only *100 and 200 mg for use in opioid tolerant patients only | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MS CONTIN® (morphine sulfate controlled-release) Tablets CII 15 mg 30 mg 60 mg 100 mg * 200 mg * | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | 6c826b0a-ac87-48cc-a780-9a4a2118e8a8 | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | CII Morphine Sulfate Extended-Release Tablets 15 mg, 30 mg, 60 mg, 100 mg* and 200 mg* | 5 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | dfe97a3d-247d-4dda-a641-1a95196cd8d8 | 1 | |
| morphine sulfate | ACTIVE INGREDIENT | X3P646A2J0 | DepoDur ® (morphine sulfate extended-release liposome injection) CII Rx Only | 5 | |
| morphine sulfate | ACTIVE INGREDIENT | X3P646A2J0 | AVINZA ® C II (morphine sulfate extended-release capsules) 30 mg, 60 mg, 90 mg, 120 mg R x Only | 1 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | Morphine Sulfate Extended-Release Tablets C-II Rx only 30340-2 | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3678 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3674 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3612 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE ER (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3553 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3413 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3395 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3375 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3372 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | AVINZA (MORPHINE SULFATE) CAPSULE, COATED, EXTENDED RELEASE AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3187 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3057 | |
| morphine sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2084 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATEER ER (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2008 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET [BRYANT RANCH PREPACK] | 1004 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 393 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, EXTENDED RELEASE [QUALITEST PHARMACEUTICALS] | 21 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION, CONCENTRATE [LANNETT COMPANY, INC.] | 19 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.] | 19 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [ROXANE LABORATORIES, INC] | 14 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 13 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | EMBEDA (MORPHINE SULFATE AND NALTREXONE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 12 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 12 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.] | 11 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | AVINZA (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 10 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 10 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [MALLINCKRODT, INC.] | 10 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 10 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [ACTAVIS KADIAN LLC] | 9 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [TRIS PHARMA INC] | 9 | |
| morphine sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MS CONTIN (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [PURDUE PHARMA LP] | 9 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 8 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 7 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [RHODES PHARMACEUTICALS L. P.] | 7 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [WATSON LABORATORIES, INC.] | 6 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 6 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 6 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 6 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.] | 6 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 5 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [VISTAPHARM INC.] | 5 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET [BRYANT RANCH PREPACK] | 5 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | ASTRAMORPH (MORPHINE SULFATE) INJECTION [ ASTRAZENECA LP] | 4 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE (MORPHINE SULFATE ) INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 4 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.] | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [PADDOCK LABORATORIES, LLC] | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [QUALITEST PHARMACEUTICALS] | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET [ROXANE LABORATORIES, INC] | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | DURAMORPH (MORPHINE SULFATE) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN ER (MORPHINE SULFATE) CAPSULE [ST MARYS MEDICAL PARK PHARMACY] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 3 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION [MERIDIAN MEDICAL TECHNOLOGIES, INC.] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE ORAL SOLUTION SOLUTION MORPHINE SULFATE SOLUTION [CARACO PHARMACEUTICAL LABORATORIES, LTD.] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [ATLANTIC BIOLOGICALS CORPS] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [WATSON LABORATORIES, INC.] | 3 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [BRYANT RANCH PREPACK] | 2 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION [AMPHASTAR PHARMACEUTICALS, INC.] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 2 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC. ] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 2 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | INFUMORPH 200 (MORPHINE SULFATE) INJECTION, SOLUTION INFUMORPH 500 (MORPHINE SULFATE) INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE EXTENDED RELEASE TABLET [BRYANT RANCH PREPACK] | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION MORPHINE SULFATE INJECTION, SOLUTION [AMPHASTAR PHARMACEUTICALS, INC.] | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [PRECISION DOSE INC.] | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SOLUTION [SAFECOR HEALTH, LLC] | 1 | |
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE SUPPOSITORY [PADDOCK LABORATORIES, LLC] | 1 | |